Antelope Surgical Solutions - Lightning Pitch

Why It Matters

Real‑time fluorescence guidance could boost surgical accuracy, accelerating adoption of precision oncology and generating significant commercial opportunities.

Key Takeaways

• Real-time fluorescence imaging improves tissue differentiation during surgery.
• Portable multi-channel system integrates with robotic, endoscopic, and open-field platforms.
• IND-cleared tracer works alongside existing market tracers for flexibility.
• Initial focus on urologic oncology, expanding to broader solid tumors.
• Patents pending; pursuing 510(k) clearance and licensing revenue model.

Summary

Antelope Surgical Solutions introduced a portable, multi‑channel fluorescence imaging platform that provides real‑time tissue differentiation during operations. The system color‑codes cancer, blood vessels, lymph nodes, nerves, and other critical structures, aiming to overcome current surgical limitations.

The device integrates with robotic systems, standard operating‑room endoscopes—both rigid and flexible—and open‑field imaging setups. It supports the company’s IND‑cleared tracer as well as existing market tracers, creating a flexible, probe‑agnostic platform for surgery and biopsy across multiple indications.

Founder‑CEO Amy highlighted that the initial market focus is urologic oncology, with plans to expand into broader solid‑tumor surgeries. She noted existing clinical partnerships, pending patents, and a clear regulatory pathway toward 510(k) clearance, followed by licensing and product commercialization.

If successful, Antelope’s technology could markedly improve surgical precision, reduce intra‑operative complications, and open a new revenue stream in the growing intra‑operative imaging market.